Coronary heart disease and estrogen plus progestin treatment

the "burden" of the evidence

Autores

  • Álvaro Nagib Atallah SPMJ

Downloads

Não há dados estatísticos.

Referências

Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280(7):605-13.

Eccles M, Freemantle N, Mason J. North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care. Br Med J 1998;316(7139):1232-5.

Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350(9084):1047-59.

Downloads

Publicado

1999-03-03

Como Citar

1.
Atallah Álvaro N. Coronary heart disease and estrogen plus progestin treatment: the "burden" of the evidence. Sao Paulo Med J [Internet]. 3º de março de 1999 [citado 12º de maio de 2026];117(2):47-8. Disponível em: https://periodicosapm.emnuvens.com.br/spmj/article/view/2443

Edição

v. 117 n. 2 (1999)

Seção

Editorial

Licença

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.